PRMT5 drugs for Non-Small Cell Lung Cancer

5 tracked PRMT5 drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the PRMT5 page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.

2 Phase 1/21 Phase 12 preclinical / unstaged

The roster

← all PRMT5 drugs